ImmunoRx Pharma Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Intravenous Administration of IRX-010 in Healthy Participants (NCT06356259) | ImmunoRx Pharma Inc. | 2023-06-07 |
Track ImmunoRx Pharma Inc. automatically
Every clearance here is in the API, with alerts when new ones post.